Latest S-1 registration statements

Seaport Entertainment Group is offering transferable subscription rights to existing stockholders to purchase up to 7,000,000 shares of common stock at $25 per share, aiming to raise $175 million.

Silexion Therapeutics aims to raise up to $15 million through an equity line of credit with White Lion Capital, as detailed in a recent S-1 filing.

FrontView REIT, an internally-managed net-lease REIT focused on outparcel properties, has filed for an initial public offering (IPO) to fuel its growth strategy.

First Choice Healthcare Solutions amends its S-1 registration for a proposed public offering of common stock and resale by selling stockholders.

Yoshiharu Global Co. has filed an amendment to its Form S-1 registration statement for the resale of up to 400,000 shares of its Class A common stock by Alumni Capital LP.

Bolt Projects Holdings, Inc. is registering for the resale of common stock and private placement warrants following its recent business combination.

zSpace, Inc., a leading provider of AR/VR educational technology, has filed for an IPO to raise capital for growth initiatives, including software development and market expansion.

Tenon Medical, Inc. files an amendment to its Form S-1 registration statement to include the form of a Securities Purchase Agreement as an exhibit.

CXApp Inc. has filed an amendment to its Form S-1 registration statement, indicating a potential resale of common stock and warrants by selling securityholders.

Cartesian Therapeutics files an amendment to its S-1 registration statement to allow selling stockholders to resell up to 6.5 million shares of common stock.

Synergy CHC Corp is planning a public offering of 2,000,000 shares of common stock, aiming for a Nasdaq listing and growth initiatives.

BKV Corporation's amended S-1 filing highlights its focus on natural gas production, midstream operations, power generation, and carbon capture, with a commitment to achieving net zero emissions.

Tenon Medical is offering up to 1,708,428 shares of common stock, along with warrants, to fund sales, marketing, and general corporate purposes.

MBX Biosciences, a clinical-stage biopharmaceutical company, files an amendment to its S-1 registration statement for a proposed initial public offering of 8,500,000 shares of common stock, aiming to raise approximately $114.8 million for continued development of its precision peptide therapies.

CytoDyn Inc. is registering for resale up to 486.6 million shares of its common stock by selling stockholders, as the company continues clinical development of leronlimab for various indications.

Mullen Automotive is registering for resale up to 350 million shares of its common stock by selling stockholders, derived from convertible notes and warrants.

Greenlane Holdings has filed an amendment to its Form S-1 registration statement, covering the offering and resale of up to 7,090,911 shares of common stock by selling stockholders.

Dynasty Acquisition Co. issues senior unsecured notes due in 2027, outlining terms, covenants, and agreements for the benefit of noteholders and the trustee.

Elevai Labs Inc. aims to raise up to $8 million through a public offering of common stock, pre-funded warrants, and accompanying Series A and Series B warrants.

Drugs Made In America Acquisition Corp., a blank check company targeting the pharmaceutical industry, has filed an amendment to its S-1 registration statement for a proposed $500 million initial public offering.

Invizyne Technologies Inc. files an amendment to its Form S-1 registration statement for a $15 million initial public offering, including a unique investor rights offering.

Tavia Acquisition Corp., a newly formed blank check company, aims to raise $175 million through an IPO to pursue business combinations in energy transition, circular economy, and food technologies.

Westwater Resources files for a potential $30 million stock offering through an agreement with Lincoln Park Capital Fund, aiming to bolster its graphite business and working capital.

GeoVax Labs files an S-1 registration statement for the resale of up to 975,610 shares of common stock by a selling stockholder, derived from a recent private placement.

GeoVax Labs files an S-1 registration for the resale of up to 1.7 million shares of its common stock, potentially generating proceeds for the selling stockholder upon warrant exercise.

KinderCare Learning Companies, the largest private provider of early childhood education and care in the U.S., has filed for an initial public offering on the New York Stock Exchange.

SSHT S&T Group Ltd. is launching a direct public offering of 100 million shares at $0.01 each to raise capital for working capital and general corporate purposes.

Bicara Therapeutics updates its bylaws, detailing stockholder meeting procedures and director responsibilities, as it prepares for its initial public offering.

Zenas BioPharma, a clinical-stage biopharmaceutical company, is seeking to raise $180.7 million through an initial public offering to advance its immunology-based therapies.

PACS Group, Inc. has filed a registration statement to increase the number of shares offered in its initial public offering by approximately $120.1 million.